Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study of the Safety, Tolerability and Efficacy of E2007 in Parkinson's Disease Patients With "Wearing Off" Motor Fluctuations and "On" Period Dyskinesias [Phase 2]

View source ↗

Summary

A Phase 2 randomized, double-blind, placebo-controlled, dose-ranging study evaluating E2007 for safety, tolerability, and efficacy in Parkinson's disease patien…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• E2007

Snippet

Sponsor: Eisai Limited | Conditions: Parkinson's Disease | Phase 2 | Status: COMPLETED